CoChat
Sign Up
Cited by 266Hormonal and reproductive studiesHypothalamic control of reproductive hormonesGrowth Hormone and Insulin-like Growth Factors

Investigation, treatment and monitoring of late-onset hypogonadism in males. Official Recommendations of ISSAM

Open access
Morales, A., Lunenfeld, B.·2002·The Aging Male
DOI 10.1080/tam.5.2.74.86
Open this paper in CoChat — free accountOpen PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/tam.5.2.74.86

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 66 references couldn’t be matched to a known paper.

Research works printed but not linked: 23

  1. Kaufman JM. Hypothalamic-pituitary-gonadal funtion in aging men. Aging Male 1999;2:157
  2. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen defi- ciency in aging males. Metabolism 2000;49:1239
  3. Morales A, Heaton JPW. Hormonal erectile dysfunction: evaluation and management. Urol Clin NA 2001;28:279
  4. Kropman RF, Verdijk RM, Lyklama AAB, Nijeholt A, Roelfsma F. Routine endocrine screening in impotence: significance and cost- effectiveness. Int J Impotence Res 1991;3:87
  5. Vermeulen A. Routine endocrine screening in impotence: significance and cost effectiveness. [Editorial]. Int J Impotence Res 1991;3:85
  6. Morales A, Johnston B, Heaton JWP, Lundie M. Testosterone supplementation in hypogonadal impotence: assessment of biochemical measure- ments and therapeutic outcomes. J Urol 1997;157: 849
  7. Arlt W, Callies F, Koehler L, et al. Dehydroepi- androsterone supplementation in healthy men with an age related decline of dehydroepiandrosterone secretion. J Clin Endocrinol Metab 2001;86:4686
  8. Vaughn ED, Cox DS. Chronic administration of dehydroepiandrosterone (DHEA) does not increase serum testosterone or prostatic specific antigen (PSA) in normal men. J Urol 1998;159: 27(abstr 280)
  9. Weksler ME. Hormone replacement for men -not enough evidence to recommend routine treatment with dehydroepiandrosterone. Br Med J 1996;312: 859
  10. Liu R-Y, Zhou J-N, van Heerikhuize J, Hofman MA, Swaab DF. Decreased melatonin levels in post-mortem cerebro-spinal fluid in relation to ageing, Alzheimer's disease and apoliprotein E-e4/4 genotype. J Clin Endocrinol Metab 1999; 84:323
  11. Olcese J. Cellular and molecular mechanisms mediating melatonin action. Aging Male 1998;1: 113-28
  12. Behre HM, Simoni M, Nieschlag E. Strong association between leptin and testosterone. Clin Endocrinol 1997;47:237
  13. Finkelstein JS, Kilbanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, et al. Increases in bone density during treatment of men with idio- pathic hypogonadotrophic hypogonadism. J Clin Endocrinol Metab 1989;69:776
  14. Gooren LJG. Long term safety of the oral androgen testosterone undecanoate. J Androl 1994;15:212
  15. Bhasin S. Androgen treatment of hypogonadal men. J Clin Endocrinol Metab 1992;74:1221-4
  16. Bhasin S, Bremner WJ. Emerging issues in andro- gen replacement therapy. J Clin Endocrinol Metab 1997;82:3-7
  17. Bradwin SW, Swerdloff RS, Santen RJ. Andro- gens: risks and benefits. J Clin Endocrinol Metab 1991;73:4-7
  18. Arver S, Meikle AW, Dobbs AS, et al. Permeation enhanced testosterone transdermal systems in the treatment of male hypogonadism:long term effects. J Endocrinol 1996;148:254-9
  19. Uyanik BS, Ari Z, Gumus B, et al. Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. Jpn Heart J 1997; 38:73-7
  20. Morales A. Androgen replacement therapy and prostate safety Eur Androl 2002;37:1
  21. Wang C, Alexander G, Berman N, et al. Testos- terone replacement therapy improves mood in hypogonadal men -a clinical research center study. J Clin Endocrinol Metab 1996;81:3587-93
  22. Santamaria JD, Prior JC, Fleetham JA. Reversible reproductive dysfunction in men with sleep apnea. Clin Endocrinol (Oxf) 1988;28:461-70
  23. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997;82:2386

Cited by

Sorted by citations

Related

Authors
Morales, A., & Lunenfeld, B.
Affiliations
Queen's University (CA)
Venue
The Aging Male
Publisher
Informa UK Limited
Published
2002-01
Volume
5
Issue
2
Pages
74-86
ISSN
  • 1368-5538 (ISSN-L)
  • 1473-0790
DOI
10.1080/tam.5.2.74.86
OpenAlex
W2073823386
Cited by
266
References
66
Citations by year
2025: 5 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 14 · 2013: 8 · 2012: 9
FWCI
12.62
Type
journal article
Language
en
Open access
Locations
  • The Aging Male (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
andropause, male hypogonadism, androgen deficiency, diagnosis, treatment, monitoring, older men
MeSH terms
Aged, Aging, Androgens, Climacteric, Endocrine Glands, Humans, Hypogonadism, Male, Middle Aged, Monitoring, Physiologic, Syndrome, Testosterone, Age of Onset, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review